Clinicians and scientists at the Gardner Center for Parkinson’s Disease and Movement Disorders at the UC Neuroscience Institute are dedicated to advancing treatment and research for people who suffer from Parkinson’s disease and movement disorders.
Our multidisciplinary team of physicians is skilled and experienced in the art of accurate diagnosis and treatment. In fact, we diagnose and treat more patients with Parkinson’s disease and movement disorders than any other center in the Tri-state region.
Our team works together to determine the best course of treatment — which can include medication therapy, exercise regimens, voice therapy and deep brain stimulation (DBS) surgery — and we consider all potential options in our effort to improve a patient’s quality of life.
The Gardner Center also oversees a number of clinical trials that test new treatments for Parkinson’s disease and that explore strategies for patients who don’t seem to respond well to standard therapies.
Gardner Center physicians and scientists collaborate closely with the Michael J. Fox Foundation and the National Institutes of Health (NIH). In 2009 we were designated a Morris K. Udall Center for Parkinson’s Disease Research by the National Institute of Neurological Disorders and Stroke (NINDS), a division of NIH. The designation, now shared with Michigan State University, was accompanied by a research grant of $6.2 million over five years. The Morris K. Udall Centers of Excellence Program, named in honor of the former U.S. congressman from Utah who died in 1991 after a long battle with Parkinson’s disease, seeks to create and foster an environment that enhances research effectiveness in a multidisciplinary setting.
These national collaborations enable Gardner Center physicians and scientists to connect with their colleagues across the country in their quest for more effective treatments and, eventually, a cure for Parkinson’s disease.